Next generation stent coatings: Convergence of biotechnology and nanotechnology

Trends in Biotechnology

Volumn 30, Issue 8, 2012, Pages 406-409

  Tan, Aaron ^a   Alavijeh, Mohammad S ^b   Seifalian, Alexander M ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Pharmidex Pharmaceutical Services Ltd   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; CD34 ANTIBODY; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRINOGEN RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOSOME; MAGNETIC NANOPARTICLE; MOLECULAR SCAFFOLD; NANOCOMPOSITE; NANOFIBER; NANOPARTICLE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PLASMID DNA; POLYHEDRAL OLIGOMERIC SILSESQUIOXANE POLY (CARBONATE UREA) URETHANE; S NITROSOGLUTATHIONE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

BARE METAL STENT; BIOCOMPATIBILITY; CELL PROLIFERATION; CORONARY STENT; DRUG DISTRIBUTION; DRUG ELUTING STENT; DRUG RELEASE; ENCAPSULATION; ENDOTHELIAL PROGENITOR CELL; HUMAN; IN-STENT RESTENOSIS; LAB ON A CHIP; LETTER; NANOBIOTECHNOLOGY; NANOENCAPSULATION; OFF PUMP CORONARY SURGERY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT THROMBOSIS; THROMBOCYTE AGGREGATION; THROMBOGENICITY; THROMBOSIS;

ANGIOPLASTY, BALLOON, CORONARY; BIOTECHNOLOGY; BLOOD VESSEL PROSTHESIS; CORONARY ARTERY BYPASS; DRUG-ELUTING STENTS; HUMANS; NANOTECHNOLOGY;

EID: 84863859433     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2012.05.004     Document Type: Letter

References (11)

1. Sigwart U., et al. Intravascular stents to prevent occlusion and re-stenosis after transluminal angioplasty. N. Engl. J. Med. 1987, 316:701-706.
2. Jeremias A., Kirtane A. Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann. Intern. Med. 2008, 148:234-238.
3. Jungebluth P., et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 2011, 378:1997-2004.
4. Hammond P.T. Thin films: particles release. Nat. Mater. 2010, 9:292-293.
5. Beijk M.A., et al. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheter. Cardiovasc. Interv. 2011, 78:189-195.
6. Meyers S.R., et al. Bioactive stent surface coating that promotes endothelialization while preventing platelet adhesion. Biomacromolecules 2011, 12:533-539.
7. Ceylan H., et al. Selective adhesion and growth of vascular endothelial cells on bioactive peptide nanofiber functionalized stainless steel surface. Biomaterials 2011, 32:8797-8805.
8. Yoon J.H., et al. Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model. Yonsei Med. J. 2002, 43:242-251.
9. Nakano K., et al. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. JACC Cardiovasc. Interv. 2009, 2:277-283.
10. Fishbein I., et al. Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:159-164.
11. Stevenson C.L., et al. Reservoir-based drug delivery systems utilizing microtechnology. Adv. Drug Deliv. Rev. 2012, 10.1016/j.addr.2012.02.005.